Physician profile
Gary E Lemack
NPI 1033179486
$62,387.21
in general payments reported to CMS, 2019-2025
27 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,277 · 2020: $5,494 · 2021: $7,797 · 2022: $5,512 · 2023: $16K · 2024: $12K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Food and Beverage: $3,208 · Travel and Lodging: $2,341 · Honoraria: $1,800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,835.00 |
| Food and Beverage | $3,208.42 |
| Travel and Lodging | $2,341.25 |
| Honoraria | $1,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $122.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $8,783.18 | 2023-2025 | Gemtesa |
| Allergan, INC. | $8,714.50 | 2019-2022 | |
| Boston Scientific Corporation | $7,672.53 | 2021-2025 | Ams 800 Artificial Urinary Sphincter, Solyx Sis System, Spaceoar Vue System - 10ml |
| Verathon INC. | $7,250.00 | 2023-2024 | Npd Clinical Study |
| Purdue Pharma L.P. | $6,600.00 | 2025 | |
| Axonics, INC. | $5,890.21 | 2021-2024 | Bulkamid |
| Urovant Sciences INC | $4,335.71 | 2021-2022 | |
| Bluewind Medical | $3,895.99 | 2020-2025 | Revi |
| Medtronic, INC. | $2,708.96 | 2021-2025 | Interstim |
| Hollister Incorporated | $2,046.23 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $1,949.50 | 2019 | |
| Abbvie INC. | $675.64 | 2021-2025 | |
| Rochester Medical Corporation | $457.20 | 2020-2022 | |
| Medtronic USA, INC. | $402.53 | 2019-2020 | |
| Convatec INC. | $192.69 | 2020-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $124.99 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $111.11 | 2023-2024 | Bard Urinary Drainage Bag |
| Coloplast Corp | $109.63 | 2023 | Speedicath |
| Urogen Pharma, INC. | $100.52 | 2023-2024 | Jelmyto |
| Antares Pharma, INC. | $74.11 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Cook Medical LLC | $64.50 | 2019 | |
| Astellas Pharma US INC | $57.86 | 2019-2021 | |
| Caldera Medical, INC | $56.49 | 2021-2022 | |
| Innovation Technologies INC | $49.32 | 2024 | Irrisept |
| Novo Nordisk INC | $26.87 | 2025 | Rivfloza |
| Olympus America INC. | $21.96 | 2024 | Itind System |
| 180 Medical, INC. | $14.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Lemack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.